Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pau Llàcer

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Medicina Clinica|May 11, 2022
[Reply]Pau Llàcer, Luis Manzano, Julio Núñez
Medicina Clinica|November 17, 2018
Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatmentPau Llàcer, Antoni Bayés-Genís, Julio Núñez
European Journal of Internal Medicine|March 7, 2021
Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosisPau Llàcer, Luis Manzano, Cristina Fernández, et al.
European Journal of Internal Medicine|May 27, 2026
Refining checklist-based screening for transthyretin cardiac amyloidosis: methodological and pathophysiological considerations. Author's replyAlberto Pérez-Nieva, Pau Llàcer, Prado Salamanca-Bautista, et al.
European Journal of Internal Medicine|December 16, 2025
Heart failure with preserved ejection fraction in the elderly: Clinical, imaging, and biomarker profiles according to global longitudinal strain by cardiac magnetic resonancePau Llàcer, Marina García Melero, María Ángeles Fernández, et al.
Revista Clinica Espanola|April 4, 2026
Finerenone in heart failure with ejection fraction ≥40%: state of the art and future perspectivesPau Llàcer, Marta Cobo Marcos, Julio Nuñez, et al.
ESC Heart Failure|December 20, 2023
Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trialEnrique Santas, Irene Del Canto, Ingrid Cardells, et al.
European Heart Journal. Acute Cardiovascular Care|February 15, 2022
Comparison of chlorthalidone and spironolactone as additional diuretic therapy in patients with acute heart failure and preserved ejection fractionPau Llàcer, Julio Núñez, Marina García, et al.
International Journal of Cardiology|May 8, 2014
Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failureJulio Núñez, Pau Llàcer, Eduardo Núñez, et al.
ESC Heart Failure|March 8, 2024
Loop diuretic down-titration at discharge in patients hospitalized for acute heart failureFrançois Croset, Pau Llàcer, Julio Núñez, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Medicina Clinica|May 11, 2022
[Reply]Pau Llàcer, Luis Manzano, Julio Núñez
Medicina Clinica|November 17, 2018
Carbohydrate antigen 125 in heart failure. New era in the monitoring and control of treatmentPau Llàcer, Antoni Bayés-Genís, Julio Núñez
European Journal of Internal Medicine|March 7, 2021
Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosisPau Llàcer, Luis Manzano, Cristina Fernández, et al.
European Journal of Internal Medicine|May 27, 2026
Refining checklist-based screening for transthyretin cardiac amyloidosis: methodological and pathophysiological considerations. Author's replyAlberto Pérez-Nieva, Pau Llàcer, Prado Salamanca-Bautista, et al.
European Journal of Internal Medicine|December 16, 2025
Heart failure with preserved ejection fraction in the elderly: Clinical, imaging, and biomarker profiles according to global longitudinal strain by cardiac magnetic resonancePau Llàcer, Marina García Melero, María Ángeles Fernández, et al.
Revista Clinica Espanola|April 4, 2026
Finerenone in heart failure with ejection fraction ≥40%: state of the art and future perspectivesPau Llàcer, Marta Cobo Marcos, Julio Nuñez, et al.
ESC Heart Failure|December 20, 2023
Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trialEnrique Santas, Irene Del Canto, Ingrid Cardells, et al.
European Heart Journal. Acute Cardiovascular Care|February 15, 2022
Comparison of chlorthalidone and spironolactone as additional diuretic therapy in patients with acute heart failure and preserved ejection fractionPau Llàcer, Julio Núñez, Marina García, et al.
International Journal of Cardiology|May 8, 2014
Antigen carbohydrate 125 and creatinine on admission for prediction of renal function response following loop diuretic administration in acute heart failureJulio Núñez, Pau Llàcer, Eduardo Núñez, et al.
ESC Heart Failure|March 8, 2024
Loop diuretic down-titration at discharge in patients hospitalized for acute heart failureFrançois Croset, Pau Llàcer, Julio Núñez, et al.
Pageof 8